Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Oxford Sciences Innovation Announces £230m Fundraising

09 December 2016: Oxford, UK - Oxford Sciences Innovation announces a substantial increase of capital raised worldwide to scale innovative ideas from the University of Oxford into world class companies. OSI’s capital base stood previously at £350m, but a fresh injection of capital will now boost this to almost £600m. Some of Asia’s leading technology companies and sovereign wealth funds, as well as European industrialists, are among the wave of new investors.

Read the rest of entry »

Oxford Immunotec Announces New England Journal of Medicine Publication on Clinical Trial Results of Serological and Nucleic Acid Tests for Babesia in Blood Screening

08 December 2016: Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that the New England Journal of Medicine (“NEJM”) has published an article on a three-year clinical trial completed by Oxford Immunotec’s Imugen division, and the American Red Cross (“ARC”) to evaluate a serology and Nucleic acid Amplification Test (“NAT”) testing regime for Babesia in blood screening. The review article “Screening for Babesia microti in the US blood supply” is authored by Susan Stramer of the American Red Cross, and will appear in the December 8, 2016 print issue. Babesia, or babesia microti, is a parasitic protozoan transmitted by ticks and is particularly prevalent in the Northeastern part of the US. It infects red blood cells and can cause a di ...

Read the rest of entry »

Oxford City Council Approves New Building at The Oxford Science Park

07 December 2016: Oxford, UK - The Oxford Science Park is delighted that Oxford City Council has passed a resolution to approve its detailed planning application for a new state of the art office building, with roof terrace, comprising 61,500 sq ft (5,713 sq m), and capable of accommodating 500 employees.

Read the rest of entry »

Kiss Communications Appoint New Head of PR

05 December 2016: Cambridge, UK - Kiss Communications have announced the appointment of Kate Matthews to the position of Head of PR. This is a new role, with Kate reporting into Sarah Reakes, Managing Director. Kate has held several senior positions including Head of PR at Ware Anthony Rust in Cambridge, Board Director at Thirteen Communications and Associate Director at The Red Consultancy, both in London. She brings a wealth of management expertise and over 14 years’ experience in creating and leading integrated PR campaigns for B2B and B2C organisations. Kate’s client experience includes: Microscoft, Adobe, eBay, Flybe, Department for Education, ebookers, and learndirect. Kate said: “The KISS promise to ‘clarify the complex’ really stood out to me – as more and more brands compete for space, the ability to create simple but impactful ideas that cut through the noise is a real must for any successful agency. I have been impressed with the team’s energy and ent ...

Read the rest of entry »

Activate Science Extends its European programme into the Nordics

05 December 2016: Loughborough, UK – Thermo Fisher Scientific, the world leader in serving science, today announced it has delivered 34 events across Europe in 2016, including Sweden, Norway and Finland which came into the mix for the first time. Emily Quinton, European marketing communications manager, commented: “This has been a great year for Activate Science. The programme continues to go from strength to strength and has extended into 11 countries, reaching nearly 3,000 delegates.” Activate Science events are aimed at all laboratory personnel, including anyone who uses or purchases products. It is a great opportunity to network and speak directly at a customer’s location. Delegates have commented that they value being able to talk to suppliers in a relaxed atmosphere away from the laboratory. Attendees also attend seminars covering topics relevant to their work today, learning about new techniques and developments to enable them to make the world healthier, cleaner and safer ...

Read the rest of entry »

Oxford BioMedica and Orchard Therapeutics Announce Strategic Alliance

29 November 2016: London & Oxford, UK - Orchard Therapeutics, a biotechnology company dedicated to bringing transformative ex-vivo gene therapies to patients with serious and life-threatening orphan diseases announces today that it has entered into a strategic alliance with Oxford BioMedica plc, a world-leading company in gene and cell therapy. Under the terms of the collaboration and licence agreement, Oxford BioMedica has granted an exclusive intellectual property licence to Orchard for collaboration programmes, and will provide process development services and manufacture clinical and commercial GMP-grade lentiviral vectors for Orchard. Oxford BioMedica will receive a 1.95% equity stake in Orchard and will be entitled to royalties on future sales of products covered by the collaboration. The process development arrangements include performance-related incentives, through which Oxford BioMedica could receive a further 1.95% equity stake in Orchard. The agreement is an important milestone for Orcha ...

Read the rest of entry »

Wickham Laboratories Expands Sterility Testing Facilities

29 November 2016: Gosport, UK - Wickham Laboratories announces the expansion of our service offerings once again within our sterility department.  Due to a marked increase in the volume of sterility testing our sterility department has been engaged in over the past year, a refurbishment project was carried out in September to allow space for an additional isolator unit. The addition of a fourth isolator, scheduled for completion in early 2017, will expand our capacity for testing by over 30% and reduce potential delays in turnaround time.  This is the second expansion of our sterility department in the past two years and we are pleased to have the opportunity to continue to provide both our existing and new clients with a high quality sterility testing service they can rely upon. Company Overview As a GMP/GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing, research an ...

Read the rest of entry »

AMSBIO Expands Catalogue with New Range of Human Endothelial Progenitor Cells

24 November 2016: Abingdon, UK - Human endothelial progenitor cells are a primitive cell type. They are bone marrow derived cells with properties similar to embryonic angioblasts. Progenitor cells migrate into the blood stream and are able to differentiate into a variety of mature vascular endothelial cell types. EPC play an important role in both angiogenesis and vasculogenesis. Compared to specific mature types of endothelial cells such as HMVECs and HUVECs, human EPC are more suitable for cell-based screening of anti-cancer drugs. Endothelial progenitor cells also have an impact on aging and smoking-related diseases, thereby offering beneficial research and drug discovery use in these areas.

Read the rest of entry »

PCI Clinical Services Announces Further Expansion of its Cryogenic Storage Capability

17 November 2016: Bridgend, UK & Philadelphia, USA – Bridgend increase followed by expansion at the Rockford Illinois site.  The leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is extending its current Cryogenic storage capabilities to its Rockford, Illinois operations, complementing the specialised capability currently offered at its Bridgend, UK centre of excellence for Clinical Trial Services.

Read the rest of entry »

Oxford Immunotec Ranked Among Deloitte’s 2016 Technology Fast 500™

16 November 2016: Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercialising proprietary tests for the management of underserved immune-regulated conditions today announced that it has been included in Deloitte’s 2016 Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. Oxford Immunotec’s US subsidiary was ranked 353rd in the list of 500, based upon Deloitte’s assessment that the Company grew annual revenue 204 percent from fiscal year 2012 to 2015.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.